Pharma bosses and ministers to shape future drug pricing regime
Some of the global pharmaceutical industry's top executives are to form a new panel with the government aimed at devising a new pricing regime for key medicines.
The head of Britain's biggest energy supplier has claimed his competitors oppose proposals for so-called postcode pricing because they financially benefit from the current system.
The UK's first safer drug consumption room should not be seen as a "silver bullet" to tackle Scotland's drug deaths crisis, a Westminster committee has said.
We process personal data about users of our site, through the use of cookies and other technologies, to deliver our services, personalize advertising, and to analyze site activity. We may share certain information about our users with our advertising and analytics partners. For additional details, refer to our Privacy Policy.
By clicking "I AGREE" below, you agree to our Privacy Policy and our personal data processing and cookie practices as described therein. You also acknowledge that this forum may be hosted outside your country and you consent to the collection, storage, and processing of your data in the country where this forum is hosted.